Homocysteine and P wave dispersion in patients with heart transplantation

Acampa M, Lazzerini PE, Guideri F, Rechichi S, Capecchi PL, Maccherini M, Laghi‐Pasini F. Homocysteine and P wave dispersion in patients with heart transplantation. 
Clin Transplant 2011: 25: 119–125. © 2009 John Wiley & Sons A/S.

[1]  Yanjie Lu,et al.  Homocysteine modulates sodium channel currents in human atrial myocytes. , 2009, Toxicology.

[2]  T. Murohara,et al.  Circulating homocysteine levels in patients with radiofrequency catheter ablation for atrial fibrillation. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[3]  J. Kobashigawa,et al.  Supraventricular tachycardia after orthotopic cardiac transplantation. , 2008, Journal of the American College of Cardiology.

[4]  Yanjie Lu,et al.  HOMOCYSTEINE INHIBITS POTASSIUM CHANNELS IN HUMAN ATRIAL MYOCYTES , 2007, Clinical and experimental pharmacology & physiology.

[5]  A. Wierzbicki,et al.  Homocysteine and cardiovascular disease: a review of the evidence , 2007, Diabetes & vascular disease research.

[6]  H. Jakubowski,et al.  Mechanisms of homocysteine toxicity in humans , 2007, Amino Acids.

[7]  A. Branzi,et al.  Homocysteine‐Lowering Therapy and Early Progression of Transplant Vasculopathy: A Prospective, Randomized, IVUS‐Based Study , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[8]  S. Tyagi,et al.  Homocysteine-dependent cardiac remodeling and endothelial-myocyte coupling in a 2 kidney, 1 clip Goldblatt hypertension mouse model. , 2005, Canadian journal of physiology and pharmacology.

[9]  Henggui Zhang,et al.  Role of up-regulation of IK1 in action potential shortening associated with atrial fibrillation in humans. , 2005, Cardiovascular research.

[10]  S. Tyagi,et al.  Extracellular matrix remodeling in the heart of the homocysteinemic obese rabbit. , 2005, American journal of hypertension.

[11]  A. Haverich,et al.  Increased plasma homocysteine concentrations accelerate cardiac allograft vasculopathy. , 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[12]  B. Giusti,et al.  Hyperhomocysteinemia and vitamin B6 deficiency: new risk markers for nonvalvular atrial fibrillation? , 2004, American heart journal.

[13]  H. Jakubowski.  Molecular basis of homocysteine toxicity in humans , 2004, Cellular and Molecular Life Sciences CMLS.

[14]  David R. Van Wagoner,et al.  Electrophysiological Remodeling in Human Atrial Fibrillation , 2003 .

[15]  Per Magne Ueland,et al.  Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. , 2002, JAMA.

[16]  Ali Oto,et al.  Physiological mechanisms influencing cardiac repolarization and QT interval. , 2002, Cardiac electrophysiology review.

[17]  Antonio Michelucci,et al.  P wave assessment: state of the art update. , 2002, Cardiac electrophysiology review.

[18]  Rajasekhar Ramakrishnan,et al.  Autonomic nervous system influences on QT interval in normal subjects. , 2002, Journal of the American College of Cardiology.

[19]  P. Lazzerini,et al.  Early and delayed increase in plasma homocysteine levels in heart transplanted patients. , 2002, Transplantation proceedings.

[20]  S. Tyagi,et al.  Reversal of endocardial endothelial dysfunction by folic acid in homocysteinemic hypertensive rats. , 2002, American journal of hypertension.

[21]  M. Mehra,et al.  Insights into ventricular repolarization abnormalities in cardiac allograft vasculopathy. , 2001, The American journal of cardiology.

[22]  K. Patel,et al.  Inhibition of K+ Currents by Homocysteine in Rat Ventricular Myocytes , 2001, Journal of cardiovascular electrophysiology.

[23]  M. Malik,et al.  Measurement, interpretation and clinical potential of QT dispersion. , 2000, Journal of the American College of Cardiology.

[24]  J. Townend,et al.  Homocysteine and atherothrombosis--mechanisms for injury. , 2000, European heart journal.

[25]  M. Malik,et al.  Comparison of Different Methods for Manual P Wave Duration Measurement in 12‐Lead Electrocardiograms , 1999, Pacing and clinical electrophysiology : PACE.

[26]  J. Selhub,et al.  Homocysteine and arteriosclerosis: subclinical and clinical disease associations. , 1999, Circulation.

[27]  Z. Ungvari,et al.  Electrophysiological effects of homocysteine in isolated rat right ventricular papillary muscles and left atria. , 1999, General pharmacology.

[28]  A. Kadish,et al.  Effects of autonomic stimulation and blockade on signal-averaged P wave duration. , 1995, Journal of the American College of Cardiology.

[29]  M. Malinow.  Homocyst(e)ine and arterial occlusive diseases , 1994, Journal of internal medicine.

[30]  G. Habib,et al.  Hyperhomocysteinaemia in heart transplant recipients. , 1994, European heart journal.

[31]  P Jaillon,et al.  Rate-corrected QT interval: techniques and limitations. , 1993, The American journal of cardiology.

[32]  A. Garson,et al.  How to measure the QT interval--what is normal? , 1993, The American journal of cardiology.

[33]  B. Radovancević,et al.  Prognostic value of the QTc interval after cardiac transplantation. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[34]  J. Seward,et al.  Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[35]  Y. Yi.  Homocysteine and Arterial Occlusive Diseases , 2003 .

[36]  E. Falk,et al.  Homocysteine and atherothrombosis , 2001, Lipids.